Abstract
An Anaplastic Lymphoma Kinase-rearranged Squamous Cell Lung Cancer Treated with Sequential ALK-tyrosine Kinase Inhibitor Therapy: a Case Report
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have